Concord Biotech Limited (NSE: CONCORDBIO)

Concord Biotech Market Cap

Concord Biotech has a market cap or net worth of 196.46 billion as of October 10, 2024. Its market cap has increased by 89.79% in one year.

• Market Cap: 196.46B
• Enterprise Value: 193.74B
• Revenue: 10.38B
• Ranking: n/a
• PE Ratio: 62.72
• Stock Price: 1,948.55

Market Cap Chart

Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 196.46B, an increase of 99.19%. That is a compound annual growth rate of 82.52%.

Market Cap History

Date	Market Cap	% Change
Oct 9, 2024	203.85B	32.39%
Dec 29, 2023	153.97B	56.11%